“…In recent years, cell mechanics has been recognized as a novel label-free biomarker for indicating cell states and pathological changes, and much effort has gone into this field for its practical application in biomedicine. The advent of various new technologies, especially atomic force microscopy (AFM), have enabled the measurement of biophysical properties, including cell stiffness, viscoelasticity, deformability, morphology, topography, and adhesion [39][40][41], which can serve as a marker for cellular phenotypic events, establishing a better understanding of tumor behaviors, defining the stage of cancer progression as a promising biomarker for cancer diagnosis and prognosis, and even helping to overcome cancer therapy resistance [42][43][44]. Despite some achievements, for example, cell membrane roughness of single colon cancer cells has been analyzed during apoptosis in PDT [45], other essential biophysical aspects, such as morphology and stiffness, and in particular the effects of peptide-based nanoparticles on the biophysical properties of cancer cells, have not been adequately studied.…”